Getting your Trinity Audio player ready...
Abbott Laboratories said there will be no impact on its earnings from a preliminary injunction granted against the company to Hybritech Inc., a California biotechnology firm. The injunction prevents Abbott from selling diagnostic tests using a technology that Hybritech claims it owns.
